🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🔥 fresh SoA review 🔥 JACC Journals To supplement discussion of #MRA European Society of Cardiology News European Society of Cardiology We comprehensively examine the current evidence regarding MRAs for HF and the future direction of nonsteroidal MRA research while exploring the causes of MRA underutilization.

Stay tuned for a very special episode of #DontMissABeat coming soon from #ESCCongress. Discussing all things #finerenone and #FINEARTS_HF. A deep dive into the latest therapeutic milestone for #HF and the practical implications for our patients. Muthu Vaduganathan #GDMTworks

Love this contribution from the The Cardiogenic Shock Working Group, spearheaded by the person who introduced me to #CSWG - Khue Ton !! Congratulations to you and to all the CSWG PIs. Serial shock assessment is SO important and it’s great to have good quality data to support that. Navin Kapur

🔥 📄 SEQUOIA-HCM 🔥 European Society of Cardiology #ESCCongress JACC Journals symptomatic oHCM aficamten vs placebo Improved KCCQ, 👇chest pain Led by T32 fellow, rising 🌟 Charles Sherrod Saint Luke's Mid America Heart Institute KCCQ guru and mentor John Spertus Editorial response by Nosheen Reza, MD

Can't get enough of FINEARTS-HF or maybe you're wondering what it means for spironolactone? Check out the latest episode of #DontMissABeat where Muthu Vaduganathan and Steve Greene break down the trial, results, and future research priorities. hcplive.com/view/dont-miss… #ESCCongress

Really nice break down of trial design and clinical perspectives by two outstanding trialists and cardiologists Steve Greene Muthu Vaduganathan Highly recommended POD for research-inclined FITs #ACCFIT CardioNerds #DontMissABeat

Can’t wait to try newest hot sauce by the amazing & talented Molly Altenburg - thank you Molly! Name & ingredients speak for themselves - many #CICU rounds spent trying to unravel the mystery together. Other name for this sauce: SCAI D Shock. #IYKYK #CardioTwitter🌶️🌶️🌶️

🔥🔥🔥 One stop shop for all your imaging needs re LVAD and MCS 🔥🔥🔥 American Society of Echocardiography If you are HF or critical care, as David H. Wiener, MD points out, you’ll want to read (or bookmark) this one!!

New JACC Journals #JACCHF 🫀❤️‍🩹 ‼️Rapid uptitration of #GDMT ▪️⬇️ #HF-related morbidity & mortality  🌟Regardless of underlying HF risk profile DOI: 10.1016/j.jchf.2024.04.017

Sara Inglis JACC Journals Novi Tham Eiran Gorodeski, MD, MPH Adrian da Silva Nikhil Narang, MD Jenny Thibodeau, MD, MSCS Michael H. Beasley, MD Read the on point editorial by Jenny Thibodeau, MD, MSCS #MichaelGivertz 👉 jacc.org/doi/10.1016/j.…

Does inpatient #PCI volume impact outcomes in #AMI #CardiogenicShock? Despite higher acuity, high volume PCI centers had comparable readmissions. Read our work in JACC Journals led by Kannu Bansal - authors.elsevier.com/a/1ji%7EX7tD%7…. The Warren Alpert Medical School Lifespan Health System Brown Cardiology Fellowship

New in #JACCHF: 🔥 Obesity & Weight Loss Strategies for Patients with Heart Failure Nice review of this important target in the management of #HF JACC Journals JACC HF: jacc.org/doi/10.1016/j.…

Now in JACC Journals #JACCHF, analysis ▶️ DAPA-HF+DELIVER ✅ Pts w/ recent HFH had highest clinical risk + greatest benefit post randomization for risk reduction of worsening HF + CV 💀 Pre-discharge implementation of #GDMT more important than ever tinyurl.com/4dr6y89p

🔥🔥 ☠️ for phenotypes along preshock -> CS continuum 👉 jacc.org/doi/full/10.10… JACC Journals #JACCHF Critical Care Cardiology Trials Network 🎯 Hypoperfusion +/- hypotension -> ⬆️☠️ 🎯 normotensive CS -> distinct CS phenotype 🎯 Identify pre-& early shock to improve #CardiogenicShock outcomes

🔴Dapagliflozin and Timing of Prior Heart Failure Hospitalization: A Patient-Level Meta-Analysis of DAPA-HF and DELIVER Via Nikhil Narang, MD 👥 11,007 DAPA-HF & DELIVER 📍primary outcome was the composite of worsening HF or CV💀 👥 12.4% were 🏥 for HF within 3 months of

🚨 Just released! 🚨 Excited to share our new preprint on the Common Longitudinal ICU Data Format (CLIF)! This open-source format standardizes ICU data for federated research, advancing AI and critical care research. Check it out: (medrxiv.org/content/10.110…) #ICU #DataScience #AI

After the definition of pulmonary hypertension was changed, many patients with HF and group 2 PH meet the hemodynamic criteria of PAH (PAP>20, PVR>2) and can be misclassified. We studied patients with CardioMEMS and found that 1) PH is extremely prevalent at>85% and 2) 16% of

🔥🔥🔥 An essential resource! Outstanding review on steroidal versus nonsteroidal MRA in HF. All trials, mechanisms, profiles. Andrew J Sauer MD Harriette Van Spall, MD MPH Andrew P. Ambrosy, MD #JACCHF JACC Journals jacc.org/doi/10.1016/j.…

Gender & Race Differences in HeartMate3 LVAD as a Bridge to Transplantation JACC Journals #JACCHF jacc.org/doi/10.1016/j.… Black patients with HM3 less likely to be transplanted compared with White patients. No differences in transplant outcomes between 2 races or men & women

Now available, our JACC HF State-of-the-Art Review on weight-loss strategies for patients with HF. I hope you find it helpful for your practice.